THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Brevan Howard Capital Management LP's Holding History (CIK: 0001512857)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024

Shares 11,093 Value ($000) $89 Avg Close $8.66 Range $7.44 - $10.42

Q2 2024

Shares 29,665 Value ($000) $252 Avg Close $9.03 Range $8.13 - $10.44

Q1 2024

Shares 24,607 Value ($000) $221 Avg Close $9.27 Range $8.21 - $11.71

Q4 2023

Shares 25,268 Value ($000) $284 Avg Close $10.06 Range $8.52 - $11.57

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2024	11,093	$89	$8.66	$7.44 - $10.42
Q2 2024	29,665	$252	$9.03	$8.13 - $10.44
Q1 2024	24,607	$221	$9.27	$8.21 - $11.71
Q4 2023	25,268	$284	$10.06	$8.52 - $11.57